Neurociencias
Departamento
Catalina
Requejo Rodríguez
Publicaciones en las que colabora con Catalina Requejo Rodríguez (18)
2021
-
The effect of 5-HT1A receptor agonists on the entopeduncular nucleus is modified in 6-hydroxydopamine-lesioned rats
British Journal of Pharmacology, Vol. 178, Núm. 12, pp. 2516-2532
2020
-
6-Hydroxydopamine lesion and levodopa treatment modify the effect of buspirone in the substantia nigra pars reticulata
British Journal of Pharmacology, Vol. 177, Núm. 17, pp. 3957-3974
-
Changes in Day/Night Activity in the 6-OHDA-Induced Experimental Model of Parkinson’s Disease: Exploring Prodromal Biomarkers
Frontiers in Neuroscience, Vol. 14
2019
-
Beneficial effects of n-3 polyunsaturated fatty acids administration in a partial lesion model of Parkinson's disease: The role of glia and NRf2 regulation
Neurobiology of Disease, Vol. 121, pp. 252-262
-
Machine Learning Methods for Environmental-Enrichment-Related Variations in Behavioral Responses of Laboratory Rats
Lecture Notes in Computer Science (including subseries Lecture Notes in Artificial Intelligence and Lecture Notes in Bioinformatics)
-
Machine learning methods for environmental-enrichment-related variations in behavioral responses of laboratory rats
Understanding the Brain Function and Emotions: 8th International Work-Conference on the Interplay Between Natural and Artificial Computation, IWINAC 2019 Almería, Spain, June 3–7, 2019 Proceedings, Part I (Springer Suiza), pp. 420-427
-
Nanodelivery of therapeutic agents in Parkinson's disease
Progress in Brain Research (Elsevier B.V.), pp. 263-279
2018
-
Correction to: Deleterious Effects of VEGFR2 and RET Inhibition in a Preclinical Model of Parkinson’s Disease (Molecular Neurobiology, (2018), 55, 1, (201-212), 10.1007/s12035-017-0733-x)
Molecular Neurobiology
-
Deleterious effects of VEGFR2 and RET inhibition in a preclinical model of Parkinson’s disease
Molecular Neurobiology, Vol. 55, Núm. 1, pp. 201-212
-
Nanodelivery of cerebrolysin and rearing in enriched environment induce neuroprotective effects in a preclinical rat model of Parkinson’s disease
Molecular Neurobiology, Vol. 55, Núm. 1, pp. 286-299
2017
-
Morphological Changes in a Severe Model of Parkinson’s Disease and Its Suitability to Test the Therapeutic Effects of Microencapsulated Neurotrophic Factors
Molecular Neurobiology, Vol. 54, Núm. 10, pp. 7722-7735
-
Nanoformulation: A Useful Therapeutic Strategy for Improving Neuroprotection and the Neurorestorative Potential in Experimental Models of Parkinson's Disease
International Review of Neurobiology (Academic Press Inc.), pp. 99-122
2015
-
Morphofunctional changes in a rat model of Parkinson's disease - Effects of neurotrophic factors administration
Morphofunctional changes in a rat model of Parkinson's disease - Effects of neurotrophic factors administration
-
Topographical Distribution of Morphological Changes in a Partial Model of Parkinson’s Disease—Effects of Nanoencapsulated Neurotrophic Factors Administration
Molecular Neurobiology, Vol. 52, Núm. 2, pp. 846-858
2014
-
Angioglioneurinas y enriquecimiento ambiental: una prometedora alianza para la restauración del cerebro
Neuro-protección en enfermedades neuro y heredo-degenerativas (OmniaScience), pp. 209
-
Angioglioneurins and environmental enrichment: A promising partnership for the restoration of the brain
NEUROPROTECCION EN ENFERMEDADES NEURO Y HEREDO DEGENERATIVAS (OMNIASCIENCE), pp. 209-255
-
Increased antiparkinson efficacy of the combined administration of VEGF- and GDNF-loaded nanospheres in a partial lesion model of Parkinson's disease
International Journal of Nanomedicine, Vol. 9, Núm. 1, pp. 2677-2687
2013
-
In vivo administration of VEGF- and GDNF-releasing biodegradable polymeric microspheres in a severe lesion model of Parkinson's disease
European Journal of Pharmaceutics and Biopharmaceutics, Vol. 85, Núm. 3 PART B, pp. 1183-1190